Discovery Structure Properties Gene, mRNA, and precursor Regulation of synthesis Receptors Agonists Biological functions Clinical implications
ChemicalBook > CAS DataBase List > GUANYLIN (RAT)

GUANYLIN (RAT)

Discovery Structure Properties Gene, mRNA, and precursor Regulation of synthesis Receptors Agonists Biological functions Clinical implications
Product Name
GUANYLIN (RAT)
CAS No.
144940-98-7
Chemical Name
GUANYLIN (RAT)
Synonyms
GUCA2;GUCA2A;GUANYLIN;Cys7-Cys15);GUANYLIN (RAT);GUANYLIN (RAT, MOUSE);PNTCEICAYAACTGC(Disulfide bridge:Cys4-Cys12;ADLCEICAFAACTGCL(Disulfide bridge:Cys4-Cys12;ANTI-GUCA2A (CENTER) antibody produced in rabbit;PRO-ASN-THR-CYS-GUE-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS
CBNumber
CB2387291
Molecular Formula
C60H90N16O22S4
Formula Weight
1515.71
MOL File
144940-98-7.mol
More
Less

GUANYLIN (RAT) Property

storage temp. 
−20°C
form 
solid
color 
white
Water Solubility 
Soluble in water
More
Less

Safety

Safety Statements 
22-24/25
WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

TRC
Product number
G844705
Product name
Guanylin(rat,mouse)
Packaging
100μg
Price
$70
Updated
2021/12/16
Usbiological
Product number
482431
Product name
GUCA2A
Packaging
100ul
Price
$529
Updated
2021/12/16
Usbiological
Product number
G9805-02
Product name
Guanylin
Packaging
1mg
Price
$531
Updated
2021/12/16
Usbiological
Product number
G9805-01
Product name
Guanylin
Packaging
1mg
Price
$531
Updated
2021/12/16
Usbiological
Product number
383190
Product name
GUCA2A
Packaging
96Tests
Price
$729
Updated
2021/12/16
More
Less

GUANYLIN (RAT) Chemical Properties,Usage,Production

Discovery

GN was first isolated from the rat jejunum and its gene was identified in humans in 1992. In nonmammalian vertebrates, gn and rgn were first cloned from the Japanese eel in 2003. Except for avians, gn has also been found in other vertebrates.

Structure

GN consists of 15 aa residues that are cleaved from the C-terminus of proGN . The fourth and 12th Cys and the seventh and 15th Cys form a disulfide bond, respectively. The two rings give rise to the formation of two stereoisomers, of which only one is active. The aromatic aa residue (Tyr/Phe) at the ninth position is targeted by chymotrypsin-like proteases in the renal tubule. These features are shared among all GNs found as well as eel Rgn. Most of the 15 aa residues are conserved across vertebrate species, whereas an extra Leu residue is present in eel Rgn. The prosegment is variable with the exception of a conserved Leu/Lys-rich region located in the upstream of proGN.

Properties

The Mr and pI of human GN are 1458.7 and 4.56, respectively. GN is soluble in water, alcohol, and water-containing organic solvents. GN is stable at neutral pH, but at acidic pH, it is more easily converted to the inactive stereoisomer. GN in water is stable at -20°C for more than 1 year. Empirically, eel Rgn has been solubilized and stored like GN.

Gene, mRNA, and precursor

GN is located near UGN on chromosome 1 in humans (1p34.2). Similar colocalization on a chromosome is found in other vertebrate genome databases. Three exons divided by two introns are transcribed and translated into preproGN of 115 aa residues containing the signal peptide and the mature peptide. ProGN is released from cells and processed into GN during circulation or on the intestinal and renal tubular lumen. The mature region is conserved among vertebrate GNs and eel Rgn , although the precise processing mechanism needs to be studied in nonmammalian Gns and Rgn. No significant splice variant is known at present.

Regulation of synthesis

GN promoter sequence in the 50 -flanking region lacks typical TATA and CAAT boxes, but possesses a putative TATA-alternative motif, “TTTAAAA,” and several potential binding/responsive sites for transcription factors/elements such as AP-1, AP-2, SP1, GRE, GCF, and HNF-1 in humans and mice. HNF-1 could play a role in restricting GN expression to the intestine. In rodent and eel intestines, GN is synthesized in goblet cells. In eels, rgn could be produced in the kidney as significanly as in the intestine.

Receptors

GUCY2C, a membrane protein consisting of an extracellular ligand-binding domain, a membrane-spanning domain, a kinase-like domain, and a catalytic guanylyl cyclase (GC) domain, is the primary receptor for both GN and UGN . A shorter GUCY2C, a splice variant, is expressed in some colorectal cancer cells. In contrast to the one GUCY2C in mammals, at least two isoforms of gucy2c exist in teleost fish. At the cGMP production in COS cells expressing each eel isoform, the potency rankings of Gucy2c2 and Gucy2c1 are Gn ≥ Rgn > Ugn and Rgn ≤ Gn < Ugn, respectively. At least one gucy2c sequence has been found in other vertebrates. Furthermore, another type of GC receptor, GUCY2D, expressing in the murine olfactory epithelia, is reported to be stimulated by GN and UGN, while the presence of additional GN receptor(s) has been predicted.

Agonists

Sts produced by enterotoxigenic E. coli are exogenous ligands of GUCY2C. Sts exert stronger effects for GUCY2C than GN in mammals and substantial effects for one medaka Gucy2c (Olgc9), but not for other fish cloned Gucy2cs. Other major agonists are synthetic peptides modified from GN/UGN, linaclotide and plecanatide.

Biological functions

The primary site of GN action is the intestine where GUCY2C expression is most plentiful. The kidney, liver, gall bladder, bile duct, testis, trachea, salivary glands, and nasal mucosa are also possible target sites. In eels and medaka, the major sites of gucy2c1 and gucy2c2 expression are the intestine and kidney. In the intestine, GN is produced in goblet cells and secreted into the lumen. GN binding to the apically located GUCY2C induces Cl- and HCO3- secretion via CFTR and some SLC26 members and inhibits Na+ absorption via NHE3, which eventually drives intestinal water secretion.
GN-GUCY2C signaling suppresses intestinal tumorigenesis. In the intestine, GN is more active at pH 8.0 than at pH 5.0. Circulating and locally produced GN also acts on the renal tubule to induce natriuresis, kariuresis, and diuresis, presumably by affecting the NHE3 and K+ channel(s). However, this GN’s effects could be limited due to the degradation of GN by proteases on the brush border of the renal tubule. In eels, on the other hand, Gn and Rgn affect Cftr in the intestine, but it is notable that Gn and Rgn inhibit Nkcc2 for decreased NaCl absorption and may induce some Slc26 members for HCO3 - secretion under a seawater environment, probably for osmoregulation. In these described actions, GN is often less effective than UGN in mammals while Gn is more effective than Rgn and Ugn in eels. Concerning eel Rgn, its mRNA expression in the intestine and kidney slightly or hardly change after seawater transfer of the fish, suggesting that Rgn may have roles different from those of Gn and Ugn. In a heterologous system, eel Rgn inhibits NHE3 as does rat UGN, but is less effective than rat UGN in the rat perfused renal tubule. In addition, the olfactory GN-GUCY2D signaling in mice suggests more GN functions.

Clinical implications

There is no known disease related to GN. A function for intestinal fluid secretion has led scientists to apply GN for anticonstipation. Decreased GN mRNA expression in some colorectal cancers, promoted epithelial proliferation in the loss of GN, and decreased GN in obesity suggest a clinical application of GN to prevent the enlargement of colorectal tumors and improve obesity.

Description

Guanylin is a peptide hormone consisting of 15 aa residues that binds to the guanylyl cyclase C (GUCY2C) receptor to produce cGMP. It plays an important role in regulating ion and water transport and maintaining epithelial homeostasis in the intestine and kidney. Eel renoguanylin (Rgn) is more similar to GN than to uroguanylin (UGN), and thus is described here.

Uses

Guanylin (rat, mouse) is an endogenous intestinal guanylyl cyclase activator.

Clinical Use

Two GN/UGN agonists, linaclotide and plecanatide, have recently been approved in the United States, European Union, Japan, and other countries to treat irritable bowel syndrome and chronic constipation. They have also been approved in the United States to treat chronic idiopathic constipation and irritable bowel syndrome with constipation, respectively.

GUANYLIN (RAT) Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

GUANYLIN (RAT) Suppliers

GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Fax
86-21-61263399
Email
ymbetter@glbiochem.com
Country
China
ProdList
9981
Advantage
64
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Country
China
ProdList
42958
Advantage
64
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
15402
Advantage
60
Cellmano Biotech Limited
Tel
0551-65326643 18156095617
Fax
0551-65326641
Email
info@cellmano.com
Country
China
ProdList
1011
Advantage
55
Nanjing Leon Biological Technology Co., Ltd.
Tel
17705183659
Fax
84523390
Email
sales@njleonbiotech.com
Country
China
ProdList
5501
Advantage
55
Nanjing Peptide Biotech Ltd.
Tel
025-025-58361106-805-805 13082558573
Fax
025-58361106-806
Email
liugang@njpeptide.com
Country
China
ProdList
9980
Advantage
55
Chengdu Youngshe Chemical Co., Ltd.
Tel
+86-17380623303 +86-17380623303
Fax
028-62328193
Email
Caroline@youngshechem.com
Country
China
ProdList
4840
Advantage
58
Hangzhou Peptidego Biotech Co.,Ltd.
Tel
0571-87213919
Fax
0571-87213919
Email
Eric@peptidego.com
Country
China
ProdList
6756
Advantage
58
Nanjing Meihao Pharmaceutical Technology Co., Ltd.
Tel
meitaochem@126.com
Email
meitaochem@126.com
Country
China
ProdList
19103
Advantage
58
Hangzhou Go Top Peptide Biotech
Tel
0571-88211921
Email
sales1@gotopbio.com
Country
CHINA
ProdList
2609
Advantage
58
Career Henan Chemica Co
Tel
+86-0371-86658258 +8613203830695
Fax
0371-86658258
Email
laboratory@coreychem.com
Country
China
ProdList
30240
Advantage
58
Cellmano Biotech Limited
Tel
0551-65326643 18156095617
Fax
0551-65326641
Email
info@cellmano.com
Country
China
ProdList
999
Advantage
58
Nanjing chengqimei Biotechnology Co., Ltd
Tel
19850819832
Email
2173594524@qq.com
Country
China
ProdList
2638
Advantage
58
Gill polypeptide biopharmaceutical (dalian) co., LTD
Tel
021-61263455 13167021076
Email
amy@glschina.com
Country
China
ProdList
8745
Advantage
58
Nanjing TGpeptide Biotechnology Co.,Ltd.
Tel
18115476705
Email
sales@tgpeptide.com
Country
China
ProdList
3058
Advantage
58
Hangzhou Go Top Peptide Biotech
Tel
0571-88211921 13355716090
Email
Sales@gotopbio.com
Country
China
ProdList
2859
Advantage
58
Energy Chemical
Tel
021-58432009 400-005-6266
Fax
021-58436166
Email
marketing1@energy-chemical.com
Country
China
ProdList
44808
Advantage
58
cjbscvictory
Tel
13348960310 13348960310
Email
3003867561@qq.com
Country
China
ProdList
10002
Advantage
58
TCI (Shanghai) Chemical Trading Co., Ltd.
Tel
021-021-61109150
Fax
021-61105897
Email
sales@tcisct.com
Country
China
ProdList
31121
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
13675144456
Email
alan.chow@synzest.com
Country
China
ProdList
9470
Advantage
58
Nanjing Yuanpeptide Biotech Co.,Ltd.
Tel
18168071971
Email
support@yuan-peptide.com
Country
China
ProdList
2979
Advantage
58
Chengdu Jinglin Biotechnology Co., Ltd.
Tel
17711399154
Email
3211919385@qq.com
Country
China
ProdList
1815
Advantage
58
Shaoxing Junyu Biotechnology Co., LTD
Tel
0571-88211921 15572296305
Email
sales4@gotopbio.com
Country
China
ProdList
5128
Advantage
58
Hangzhou Sinoda Pharmaceutical Technology Co. LTD
Tel
0571-87213919 17306812703
Email
3007955328@qq.com
Country
China
ProdList
6445
Advantage
58
Hangzhou Baige Pharmaceutical Technology Co. , Ltd.
Tel
0571-85350119 15888826472
Email
15888826472@163.com
Country
China
ProdList
2729
Advantage
58
Shanghai HongTide Biotechnology Co.,Ltd.
Tel
19961912513
Email
sales@hongtide.com
Country
China
ProdList
4597
Advantage
58
Combio (Suzhou) Ltd.
Tel
0512-51886999 17706251929
Email
office@combiosz.com
Country
China
ProdList
2981
Advantage
58
https://hanhongsci.com/
Tel
021-54306202 18917919676
Email
info@hanhongsci.com
Country
China
ProdList
29977
Advantage
58
Shanghai Toyang Biotechnology Co., LTD
Tel
021-59555769 13524932310
Fax
021-50342869
Email
1405894150@qq.com
Country
China
ProdList
8221
Advantage
58
Nanjing Yushengkang Biotechnology Co., Ltd
Tel
13327808530
Email
2670965693@qq.com
Country
China
ProdList
2179
Advantage
58
Zhejiang Jiekun Biotechnology Co., Ltd
Tel
0571-88211951 13735575465
Email
sales1@gotopbio.com
Country
China
ProdList
4904
Advantage
58
Taiyuan Bailihengkang Biotechnology Co., Ltd
Tel
19135651983 19135651983
Email
18611134419@163.com
Country
China
ProdList
4416
Advantage
58
Hangzhou Beiputai Biopharmaceutical Co., Ltd
Tel
0571-85350119 13305819357
Email
bptsales@163.com
Country
China
ProdList
3849
Advantage
58
Shanghai Daken Advanced Materials Co.,Ltd
Tel
+86-371-66670886
Email
info@dakenam.com
Country
China
ProdList
18777
Advantage
58
Changsha MOL Changes Biotechnology Co., Ltd.
Tel
+8619375158599
Email
info@molchanges.com
Country
China
ProdList
5225
Advantage
58
Shenzhen Nexconn Pharmatechs Ltd
Tel
+86-755-89396905 +86-15013857715
Email
admin@nexconn.com
Country
China
ProdList
10310
Advantage
58
Nanjing TGpeptide
Tel
+86-13347807150 +86-13347807150
Email
support@tgpeptide.com
Country
China
ProdList
3279
Advantage
58
Chengdu Youngshe Chemical Co., Ltd.
Tel
+8618108235634
Email
Cecilia@youngshechem.com
Country
China
ProdList
2345
Advantage
58
Shanghai Hao Zhun Biological Technology Co., Ltd.
Tel
--
Fax
--
Email
info@zzsrm.com
Country
CHINA
ProdList
6650
Advantage
58
Beijing Taize Ruida Technology Co., Ltd.
Tel
--
Fax
--
Email
taizeorder@163.com
Country
CHINA
ProdList
6536
Advantage
58
Beijing Bi Orange Blue Biotechnology Co., Ltd.
Tel
--
Fax
--
Email
bo49855987@163.com
Country
CHINA
ProdList
6827
Advantage
58
Beijing Shengke Boyuan Biotechnology Co., Ltd.
Tel
--
Fax
--
Email
978560024@qq.com
Country
CHINA
ProdList
6005
Advantage
58
Beijing Chief-East Tech Co.,Ltd (Qwbio)
Tel
--
Fax
--
Email
info@qwbio.com
Country
China
ProdList
6912
Advantage
50
Absin Bioscience Inc.
Tel
--
Fax
--
Email
chenjw@absin.cn
Country
CHINA
ProdList
6654
Advantage
58
Beijing Bai Ao Si Biotechnology Co., Ltd.
Tel
--
Fax
--
Email
yangmei@bioneeds.net
Country
CHINA
ProdList
6999
Advantage
58
Guangzhou Ruiboao Biotechnology Co., Ltd.
Tel
--
Fax
--
Email
info@raybiotech.com
Country
CHINA
ProdList
2408
Advantage
58
Wuhan Aibotek Biotechnology Co., Ltd.
Tel
--
Fax
--
Email
tech@abclonal.com
Country
CHINA
ProdList
6796
Advantage
58
Suzhou Ruinuode Biotechnology Co., Ltd.
Tel
--
Fax
--
Email
2090855807@qq.com
Country
CHINA
ProdList
6063
Advantage
58
Shanghai Qiangyao Biological Technology Co., Ltd.
Tel
--
Fax
--
Email
caiwuchinapeptides@126.com
Country
CHINA
ProdList
1253
Advantage
58
Shanghai Qunji Biological Technology Co., Ltd.
Tel
--
Fax
--
Country
CHINA
ProdList
6971
Advantage
58

144940-98-7, GUANYLIN (RAT)Related Search:


  • PRO-ASN-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS
  • PRO-ASN-THR-CYS-GUE-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS
  • H-Pro-Asn-Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala-Ala-Cys-Thr-Gly-Cys-OH(Cys4-Cys12, Cys7-Cys15)
  • H-PRO-ASN-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS-OH
  • GUANYLIN (RAT)
  • GUANYLIN (RAT, MOUSE)
  • GUANYLIN
  • ANTI-GUCA2A (CENTER) antibody produced in rabbit
  • GUCA2
  • GUCA2A
  • PRO-ASN-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR- GLY-CYS(DISULFIDE BRIDGE: CYS4-CYS12, CYS7-CYS15)
  • PNTCEICAYAACTGC(DisulfidebondsbetweenCys4-Cys12andCys7-Cys15)
  • Cys7-Cys15)
  • PNTCEICAYAACTGC(Disulfide bridge:Cys4-Cys12
  • ADLCEICAFAACTGCL(Disulfide bridge:Cys4-Cys12
  • 144940-98-7
  • C60H90N16O22S4
  • BioChemical
  • Cell Signaling and Neuroscience
  • Cell Biology
  • Cyclic Nucleotide Metabolism
  • Guanylyl Cyclase Activators
  • G Proteins and Cyclic Nucleotides
  • Peptide
  • Cyclic Nucleotide Metabolism
  • G Proteins and Cyclic Nucleotides
  • Guanylyl Cyclase Activators